J C JR WATTS, a director at $DDS, sold 400 shares of the company on 06-05-2026 for an estimated $243,671. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.8% of their shares of this class of stock. Following this trade, they now own 10,150 shares of this class of $DDS stock.
$DDS Insider Trading Activity
$DDS insiders have traded $DDS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DDS stock by insiders over the last 6 months:
- J C JR WATTS sold 400 shares for an estimated $243,671
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$DDS Hedge Fund Activity
We have seen 174 institutional investors add shares of $DDS stock to their portfolio, and 147 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 225,756 shares (-99.7%) from their portfolio in Q1 2026, for an estimated $129,157,265
- UBS GROUP AG added 98,812 shares (+145.5%) to their portfolio in Q1 2026, for an estimated $56,531,333
- GOLDMAN SACHS GROUP INC added 55,153 shares (+182.2%) to their portfolio in Q1 2026, for an estimated $31,553,582
- BNP PARIBAS FINANCIAL MARKETS added 46,295 shares (+137.9%) to their portfolio in Q1 2026, for an estimated $26,485,832
- FIRST TRUST ADVISORS LP removed 42,355 shares (-72.5%) from their portfolio in Q1 2026, for an estimated $24,231,719
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 37,871 shares (+1331.6%) to their portfolio in Q1 2026, for an estimated $21,666,377
- NORGES BANK added 35,856 shares (+146.3%) to their portfolio in Q4 2025, for an estimated $21,740,927
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$DDS Analyst Ratings
Wall Street analysts have issued reports on $DDS in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Sell" rating on 05/06/2026
To track analyst ratings and price targets for $DDS, check out Quiver Quantitative's $DDS forecast page.
$DDS Price Targets
Multiple analysts have issued price targets for $DDS recently. We have seen 3 analysts offer price targets for $DDS in the last 6 months, with a median target of $465.0.
Here are some recent targets:
- Mauricio Serna from UBS set a target price of $465.0 on 05/06/2026
- Matthew Boss from JP Morgan set a target price of $449.0 on 02/25/2026
- Dana Telsey from Telsey Advisory Group set a target price of $650.0 on 02/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
